Towards a data-driven system for personalized cervical cancer risk stratification
Geir Severin R E Langberg1, Jan F Nygård2, Vinay Chakravarthi Gogineni3
1Department of Research, Cancer Registry of Norway (CRN), Oslo, 0379, Norway. langberg91@gmail.com.
Scientific Reports
|July 15, 2022
Summary
Personalized cervical cancer risk prediction can be improved using machine learning on longitudinal screening data. This approach addresses data imbalance and changing habits to better identify women needing further screening.
Area of Science:
- Oncology
- Biostatistics
- Machine Learning
Background:
- Cervical cancer screening programs in Nordic countries have reduced incidence and mortality.
- Current one-size-fits-all screening strategies may lead to over-screening in low-risk populations.
- Personalized risk estimation is needed to optimize screening and identify high-grade lesions.
Purpose of the Study:
- To develop and compare machine learning risk estimators for personalized cervical cancer prediction.
- To address challenges of rare disease, imbalanced data, and non-stationary screening habits.
- To treat cervical cancer risk prediction as a longitudinal forecasting problem.
Main Methods:
- Utilized longitudinal screening histories from the Cancer Registry of Norway.
- Extended existing frameworks using incremental learning for longitudinal predictions.
- Adapted imbalanced classification strategies for non-stationary data.
Main Results:
- Initial models showed bias towards normal results due to imbalanced data.
- Adapted strategies improved identification of at-risk individuals.
- Estimated absolute risk curves closely reflected observed risks in hold-out data.
Conclusions:
- Longitudinal machine learning models show promise for cervical cancer risk stratification.
- Personalized screening recommendations can be improved by these advanced prediction models.
- This approach offers a more targeted strategy than current population-level screening.
Related Concept Videos
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Cancer Survival Analysis
442
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
442
Cancer Prevention
6.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.3K
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
113
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
113


